1-8 of 8
Pim G.N.J. Mutsaers
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Population-Based External Validation of the CAR-Hematotox Score to Predict CAR T Cell Related Toxicity and Outcome in R/R LBCL Patients

Janneke W. de Boer, Kylie Keijzer, Suzanne van Dorp, Pim G.N.J. Mutsaers, Anne G.H. Niezink, Jaap A. van Doesum, Yasmina I.M. Serroukh, Louise W. Muntendam, Astrid E. Pulles, Esther J. Kret, Aniko Sijs-Szabo, Jesse Oomen, Astrid M.P. Demandt, Wendy B.C. Stevens, Maria T. Kuipers, Elise R.A. Pennings, Anne M. Spanjaart, Marie José Kersten, Margot Jak, Lisanne V. van Dijk, Marjolein W.M. van der Poel, Joost S.P. Vermaat, Tom van Meerten
Journal: Blood
Blood (2024) 144 (Supplement 1): 1747.
https://doi.org/10.1182/blood-2024-209879
Published: 2024
Journal Articles

Discordant Cellular and Humoral Responses to a 3-Dose COVID-19 mRNA Vaccination Schedule in Patients with Hematologic Malignancies

Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Bhoekhan S. Michel, Nienke J.E. Haverkate, Romy C. Dijkland, Kayleigh Van Dijk, Frederik J.H. Falkenburg, Annoek E.C. Broers, Jaap van Doesum, Robert S. Van Binnendijk, Gerco Den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit I. Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. Van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten
Journal: Blood
Blood (2022) 140 (Supplement 1): 8347–8349.
https://doi.org/10.1182/blood-2022-168991
Published: 2022
Journal Articles

Single Center Experience with Off-Label Benralizumab in Refractory Hypereosinophilic Syndrome Demonstrates a Satisfactory Safety and Efficacy Profile

Anna Aalbers, Maud Hermans, Pim G.N.J. Mutsaers
Journal: Blood
Blood (2022) 140 (Supplement 1): 1401–1402.
https://doi.org/10.1182/blood-2022-159630
Published: 2022
Journal Articles

Sickle Cell Disease Patients Mount Adequate Humoral but Reduced Cellular Responses to COVID-19 Vaccination

Cilia R. Pothast, Quincy Hofsink, Sabine Haggenburg, Michel Bhoekhan, Nienke J.E. Haverkate, Romy C. Dijkland, Kayleigh van Dijk, Frederik J.H. Falkenburg, Annoek E.C. Broers, Jaap van Doesum, Robert S. van Binnendijk, Gerco den Hartog, Judith A. Burger, Joey H. Bouhuijs, Birgit I. Lissenberg-Witte, Gaby P. Smits, Dorine Wouters, Ester M.M. van Leeuwen, Hetty J. Bontkes, Neeltje A. Kootstra, Sonja Zweegman, Arnon P. Kater, Kaz Groen, Tom van Meerten, Pim G.N.J. Mutsaers, Tim Beaumont, Marit J. van Gils, Abraham Goorhuis, Mette D. Hazenberg, Inger S. Nijhof, Mirjam H.M. Heemskerk, Caroline E. Rutten
Journal: Blood
Blood (2022) 140 (Supplement 1): 1957–1959.
https://doi.org/10.1182/blood-2022-169164
Published: 2022
Journal Articles

Poor Outcome of Patients with COVID-19 after CAR T-Cell Therapy for B-Cell Malignancies: Results from a Multicenter Study on Behalf of the European Society for Blood and Marrow Transplantation (EBMT) Infectious Diseases Working Party and the European Hematology Association (EHA) Lymphoma Group

Anne Mea Spanjaart, Per Ljungman, Rafael De La Camara, Gloria Tridello, Valentín Ortiz-Maldonado, Alvaro Urbano-Ispizua, Pere Barba, Mi Kwon, Dolores Caballero, Pierre Sesques, Emmanuel Bachy, Roberta Di Blasi, Catherine Thieblemont, Friso Calkoen, Pim G.N.J. Mutsaers, Johan A. Maertens, Livia Giannoni, Emma Nicholson, Matthew P. Collin, Carlos Pinho Vaz, Elisabetta Metafuni, Joaquín Martínez-López, Fiona Dignan, Josep-Maria Ribera, Arnon Nagler, František Folber, Robin Sanderson, Adrian Bloor, Fabio Ciceri, Nina Knelange, Francis A. Ayuk, Nicolaus Kröger, Marie José Kersten, Stephan Mielke
Journal: Blood
Blood (2021) 138 (Supplement 1): 2818.
https://doi.org/10.1182/blood-2021-149466
Published: 2021
Journal Articles

Lisocabtagene Maraleucel (liso-cel), a CD19-Directed Chimeric Antigen Receptor (CAR) T Cell Therapy, Versus Standard of Care (SOC) with Salvage Chemotherapy (CT) Followed By Autologous Stem Cell Transplantation (ASCT) As Second-Line (2L) Treatment in Patients (Pts) with Relapsed or Refractory (R/R) Large B-Cell Lymphoma (LBCL): Results from the Randomized Phase 3 Transform Study

Manali Kamdar, Scott R. Solomon, Jon E. Arnason, Patrick B. Johnston, Bertram Glass, Veronika Bachanova, Sami Ibrahimi, Stephan Mielke, Pim G.N.J. Mutsaers, Francisco J. Hernandez-Ilizaliturri, Koji Izutsu, Franck Morschhauser, Matthew A. Lunning, David G. Maloney, Alessandro Crotta, Sandrine Montheard, Alessandro Previtali, Lara Stepan, Ken Ogasawara, Timothy Mack, Jeremy S. Abramson
Journal: Blood
Blood (2021) 138 (Supplement 1): 91.
https://doi.org/10.1182/blood-2021-147913
Published: 2021
Journal Articles

For Better or for Worse: COVID-19 Vaccination during or Early after (Immuno-) Chemotherapy or Hematopoietic Progenitor Cell Transplantation

Sabine Haggenburg, Birgit I. Lissenberg-Witte, Robert S. Van Binnendijk, Gerco Den Hartog, Bhoekhan S. Michel, Nienke J.E. Haverkate, Dennis M. De Rooij, Annoek E.C. Broers, Pim G.N.J. Mutsaers, Tom Van Meerten, Jaap van Doesum, Arnon P. Kater, Sonja Zweegman, Marit J. Van Gils, Bram Goorhuis, Caroline E. Rutten, Mette D. Hazenberg, Inger S. Nijhof
Journal: Blood
Blood (2021) 138 (Supplement 1): 754.
https://doi.org/10.1182/blood-2021-150379
Published: 2021
Journal Articles

First-Line Treatment and Survival of Stage I(E) Peripheral T-Cell Lymphoma in the Netherlands; A Nationwide Population-Based Cohort Study

Frederik O. Meeuwes, Mirian Brink, Marjolein W.M. Van Der Poel, Marie José Kersten, Mariëlle Wondergem, Pim G.N.J. Mutsaers, Lara H. Böhmer, F.J. Sherida H. Woei-a-Jin, Otto J. Visser, Rimke Oostvogels, Patty M. Jansen, Karen J. Neelis, Anne P.G. Crijns, Laurien A. Daniëls, Joost S.P. Vermaat, Gerwin A. Huls, Marcel Nijland
Journal: Blood
Blood (2021) 138 (Supplement 1): 1381.
https://doi.org/10.1182/blood-2021-148038
Published: 2021